Search Results - "McFarland, Henry F."

Refine Results
  1. 1
  2. 2

    The B Cell — Old Player, New Position on the Team by McFarland, Henry F

    Published in The New England journal of medicine (14-02-2008)
    “…The benefits of therapies targeting B cells in autoimmune diseases have led to increased interest in the role of B cells in diseases that have been thought to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Myelin basic protein-specific TCR/HLA-DRB501:01 transgenic mice support the etiologic role of DRB501:01 in multiple sclerosis by Quandt, Jacqueline A, Huh, Jaebong, Baig, Mirza, Yao, Karen, Ito, Naoko, Bryant, Mark, Kawamura, Kazuyuki, Pinilla, Clemencia, McFarland, Henry F, Martin, Roland, Ito, Kouichi

    Published in The Journal of immunology (1950) (15-09-2012)
    “…Genetic susceptibility to multiple sclerosis (MS) has been linked to the HLA-DR15 haplotype consisting of DRB1*15:01(DR2b) and DRB5*01:01(DR2a) alleles. Given…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Multiple sclerosis: a complicated picture of autoimmunity by McFarland, Henry F, Martin, Roland

    Published in Nature Immunology (01-09-2007)
    “…Understanding of autoimmune diseases, including multiple sclerosis, has expanded considerably in recent years. New insights have been provided by not only…”
    Get full text
    Journal Article
  9. 9

    Tissue Distribution and Variant Characterization of Human Herpesvirus (HHV)—6: Increased Prevalence of HHV-6A in Patients with Multiple Sclerosis by Akhyani, Nahid, Berti, Rossana, Brennan, Meghan B., Soldan, Samantha S., Eaton, Joan M., McFarland, Henry F., Jacobson, Steven

    Published in The Journal of infectious diseases (01-11-2000)
    “…Human herpesvirus (HHV)—6 has been associated with the pathogenesis of multiple sclerosis (MS) on the basis of serologic, molecular, and histopathologic…”
    Get full text
    Journal Article
  10. 10

    Immunological Aspects of Demyelinating Diseases by Martin, Roland, McFarland, Henry F, McFarlin, Dale E

    Published in Annual review of immunology (01-01-1992)
    “…Primary demyelination in the central nervous system results from damage to the myelin sheath or oligodendroglia and can be produced by a variety of mechanisms,…”
    Get full text
    Journal Article
  11. 11

    Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models by Neil, Sarah, Huh, Jaebong, Baronas, Victoria, Li, Xinhui, McFarland, Henry F, Cherukuri, Murali, Mitchell, James B, Quandt, Jacqueline A

    Published in Brain, behavior, and immunity (01-05-2017)
    “…Highlights • The nitroxide radical TEMPOL given orally limits clinical disease in models of MS. • TEMPOL reduced inflammatory infiltrates and preserved…”
    Get full text
    Journal Article
  12. 12

    Immunotherapy of multiple sclerosis: Where are we? Where should we go? by Martin, Roland, Stürzebecher, Claus-Steffen, McFarland, Henry F

    Published in Nature immunology (01-09-2001)
    “…Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is…”
    Get full text
    Journal Article
  13. 13

    Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination by YUEN, Tracy J, JOHNSON, Kory R, FFRENCH-CONSTANT, Charles, MIRON, Veronique E, CHAO ZHAO, QUANDT, Jacqueline, HARRISINGH, Marie C, SWIRE, Matthew, WILLIAMS, Anna, MCFARLAND, Henry F, FRANKLIN, Robin J. M

    Published in Brain (London, England : 1878) (01-04-2013)
    “…The development of new regenerative therapies for multiple sclerosis is hindered by the lack of potential targets for enhancing remyelination. The study of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years by Bagnato, Francesca, Jeffries, Neal, Richert, Nancy D., Stone, Roger D., Ohayon, Joan M., McFarland, Henry F., Frank, Joseph A.

    Published in Brain (London, England : 1878) (01-08-2003)
    “…T1 black holes (BHs) on MRIs may represent either areas of oedema or axonal loss in patients with multiple sclerosis. BHs begin as contrast enhancing lesions…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Clustering of Non-Major Histocompatibility Complex Susceptibility Candidate Loci in Human Autoimmune Diseases by Becker, Kevin G., Simon, Richard M., Bailey-Wilson, Joan E., Freidlin, Boris, Biddison, William E., McFarland, Henry F., Trent, Jeffrey M.

    “…Human autoimmune diseases are thought to develop through a complex combination of genetic and environmental factors. Genome-wide linkage searches of autoimmune…”
    Get full text
    Journal Article
  19. 19

    Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis by Bielekova, Bibiana, Richert, Nancy, Howard, Thomas, Packer, Amy N, Blevins, Gregg, Ohayon, Joan, McFarland, Henry F, Stürzebecher, Claus-Steffen, Martin, Roland

    Published in Multiple sclerosis (01-10-2009)
    “…Rolipram, a prototypic phosphodiesterase-4 inhibitor, is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental…”
    Get full text
    Journal Article
  20. 20

    Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging by Morgen, Katrin, McFarland, Henry F., Pillemer, Stanley R.

    Published in Seminars in arthritis and rheumatism (01-12-2004)
    “…To examine the frequency of central nervous system (CNS) disease in primary Sjögren’s syndrome (pSS) and indicate ways in which cerebral magnetic resonance…”
    Get full text
    Journal Article